MX377772B - Inmunoensayo de canalización de oxígeno luminiscente utilizando tres anticuerpos y metodos de produccion y uso de los mismos. - Google Patents

Inmunoensayo de canalización de oxígeno luminiscente utilizando tres anticuerpos y metodos de produccion y uso de los mismos.

Info

Publication number
MX377772B
MX377772B MX2016011809A MX2016011809A MX377772B MX 377772 B MX377772 B MX 377772B MX 2016011809 A MX2016011809 A MX 2016011809A MX 2016011809 A MX2016011809 A MX 2016011809A MX 377772 B MX377772 B MX 377772B
Authority
MX
Mexico
Prior art keywords
antibodies
methods
producing
luminescent oxygen
oxygen channeling
Prior art date
Application number
MX2016011809A
Other languages
English (en)
Spanish (es)
Other versions
MX2016011809A (es
Inventor
David J Ledden
Donglai Lu
Eric Scott Cowden
Jay J Li
Original Assignee
Siemens Healthcare Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens Healthcare Diagnostics Inc filed Critical Siemens Healthcare Diagnostics Inc
Publication of MX2016011809A publication Critical patent/MX2016011809A/es
Publication of MX377772B publication Critical patent/MX377772B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/76—Chemiluminescence; Bioluminescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plasma & Fusion (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
MX2016011809A 2014-03-26 2015-03-24 Inmunoensayo de canalización de oxígeno luminiscente utilizando tres anticuerpos y metodos de produccion y uso de los mismos. MX377772B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461970596P 2014-03-26 2014-03-26
PCT/US2015/022209 WO2015148479A1 (en) 2014-03-26 2015-03-24 Luminescent oxygen channeling immunoassay utilizing three antibodies and methods of production and use thereof

Publications (2)

Publication Number Publication Date
MX2016011809A MX2016011809A (es) 2017-05-10
MX377772B true MX377772B (es) 2025-03-11

Family

ID=54196294

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016011809A MX377772B (es) 2014-03-26 2015-03-24 Inmunoensayo de canalización de oxígeno luminiscente utilizando tres anticuerpos y metodos de produccion y uso de los mismos.

Country Status (11)

Country Link
US (3) US20170176419A1 (cg-RX-API-DMAC7.html)
EP (2) EP3483593B1 (cg-RX-API-DMAC7.html)
JP (1) JP6596440B2 (cg-RX-API-DMAC7.html)
CN (1) CN106662532B (cg-RX-API-DMAC7.html)
AU (1) AU2015236288A1 (cg-RX-API-DMAC7.html)
CA (1) CA2942281C (cg-RX-API-DMAC7.html)
DK (2) DK3483593T3 (cg-RX-API-DMAC7.html)
ES (2) ES2884930T3 (cg-RX-API-DMAC7.html)
IL (1) IL247630A0 (cg-RX-API-DMAC7.html)
MX (1) MX377772B (cg-RX-API-DMAC7.html)
WO (1) WO2015148479A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110192109B (zh) 2016-12-09 2023-07-28 雅培医护站股份有限公司 用于扩展范围的灵敏度的联合免疫测定和磁免疫测定系统和装置
US11156607B2 (en) 2016-12-09 2021-10-26 Abbott Point Of Care Inc. Extended range immunoassay devices with immunosensor and magnetic immunosensor
WO2018107013A1 (en) * 2016-12-09 2018-06-14 Abbott Point Of Care Inc. Dual range cardiac troponin immunoassay devices and methods using immunosensor and magnetic immunosensor
US10935511B2 (en) 2016-12-09 2021-03-02 Abbott Point Of Care Inc. Ameliorated crosstalk immunoassay test device for determining a concentration of an analyte
US10871488B2 (en) 2016-12-09 2020-12-22 Abbott Point Of Care Inc. Crossover analytical systems and methods using an immunosensor and magnetic immunosensor
US10928388B2 (en) 2016-12-09 2021-02-23 Abbott Point Of Care Inc. Combined immunoassay and magnetic immunoassay methods for extended range of sensitivity
WO2019167128A1 (ja) * 2018-02-27 2019-09-06 株式会社 島津製作所 サンドイッチ型免疫測定法
US20210155680A1 (en) * 2018-02-27 2021-05-27 Shimadzu Corporation ANTIBODY THAT SPECIFICALLY RECOGNIZES N TERMINUS OF APP669-x, AND IMMUNOASSAY METHOD
CN119395003A (zh) 2018-07-30 2025-02-07 美国西门子医学诊断股份有限公司 用于进行生物素测定的试剂盒、微流体装置和方法
EP3856927B1 (en) * 2018-09-25 2023-01-11 Siemens Healthcare Diagnostics Inc. Compositions, kits, and methods for multiplex assays to correct for biotin interference in target analyte measurements
WO2021041607A1 (en) * 2019-08-29 2021-03-04 Siemens Healthcare Diagnostics Inc. Device and method to evaluate a fluid sample on a single-use multianalyte consumable
CN113125418A (zh) * 2019-12-31 2021-07-16 科美诊断技术股份有限公司 一种均相化学发光检测方法及其应用
CN113125706B (zh) * 2019-12-31 2025-07-08 科美博阳诊断技术(上海)有限公司 一种竞争性均相化学发光测定试剂盒及其应用
CN113125416B (zh) * 2019-12-31 2025-08-22 科美博阳诊断技术(上海)有限公司 一种竞争性均相化学发光检测方法及其应用
CN113125415B (zh) * 2019-12-31 2025-08-22 科美博阳诊断技术(上海)有限公司 一种竞争性均相化学发光检测方法及其应用
CN113125731B (zh) * 2019-12-31 2025-09-16 科美博阳诊断技术(上海)有限公司 一种竞争性均相化学发光测定试剂盒及其应用
CN113125704B (zh) * 2019-12-31 2025-08-22 科美博阳诊断技术(上海)有限公司 一种均相化学发光测定试剂盒及其应用
EP4138918B1 (en) * 2020-04-24 2026-07-22 Siemens Healthcare Diagnostics Inc. Calibration and quality control reagents for use with immunoassays for antibodies
CN111781385B (zh) * 2020-08-19 2023-07-18 武汉生之源生物科技股份有限公司 一种NT-proBNP检测试剂盒及其制备方法
CN114544978A (zh) * 2022-03-04 2022-05-27 美康生物科技股份有限公司 一种igf-1检测试剂盒及其制备方法和检测方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
NO164622C (no) * 1988-05-11 1990-10-24 Tore Lindmo Binaer immunometrisk partikkelbasert metode for maaling av spesifikke serum-antigener ved hjelp av vaeskestroemsmikrofotometri og et ferdigpreparert maaloppsett derav.
CA2090126C (en) 1990-08-02 2002-10-22 John W. Schrader Methods for the production of proteins with a desired function
ATE208039T1 (de) * 1991-05-22 2001-11-15 Dade Behring Marburg Gmbh Bestimmungsmethoden unter verwendung von induzierter lumineszenz
US6251581B1 (en) * 1991-05-22 2001-06-26 Dade Behring Marburg Gmbh Assay method utilizing induced luminescence
US5340716A (en) 1991-06-20 1994-08-23 Snytex (U.S.A.) Inc. Assay method utilizing photoactivated chemiluminescent label
GB9326238D0 (en) * 1993-12-23 1994-02-23 Sinvent As Method of assay
US7285418B2 (en) * 1996-06-25 2007-10-23 Hytest Ltd. Method and kit for the diagnosis of troponin I
US6248546B1 (en) * 1998-03-09 2001-06-19 Diagnostic Systems Laboratories, Inc. Assay of IGFBP complex
US6703248B1 (en) * 1999-12-15 2004-03-09 Dade Behring Marburg Gmbh Particles for diagnostic and therapeutic use
DE10064827A1 (de) * 2000-12-22 2002-06-27 Dade Behring Marburg Gmbh Nachweisverfahren
US6551788B1 (en) * 2001-11-28 2003-04-22 Beckman Coulter, Inc. Particle-based ligand assay with extended dynamic range
US6764819B2 (en) * 2002-07-16 2004-07-20 Emp Biotech Gmbh Method for chemiluminescent detection
DE112004001863T5 (de) * 2003-10-03 2006-09-07 Scantibodies Laboratory, Inc., Santee Verfahren und Verwendung von Bindungskomponenten zur Verbesserung der Testspezifität
CA2583406A1 (en) * 2004-09-20 2007-01-04 Boston Microfluidics Microfluidic device for detecting soluble molecules
EP1880218A2 (en) * 2005-04-29 2008-01-23 Beckman Coulter Fluorescence lateral flow immunoassay
US8124015B2 (en) * 2006-02-03 2012-02-28 Institute For Systems Biology Multiplexed, microfluidic molecular assay device and assay method
GB2436616A (en) * 2006-03-29 2007-10-03 Inverness Medical Switzerland Assay device and method
CN104198705B (zh) * 2006-09-21 2017-06-09 雀巢产品技术援助有限公司 检测稀有循环细胞内多种信号转导分子的基于抗体的阵列
BRPI0808551B1 (pt) * 2007-03-01 2022-04-05 Symphogen A/S Composições de anticorpo para o receptor do fator de crescimento antiepidérmico recombinante, molécula de ligação bi-específica e composição farmacêutica que os compreende
US7790401B2 (en) * 2007-08-06 2010-09-07 Siemens Healthcare Diagnostics Methods for detection of immunosuppressant drugs
US20090170218A1 (en) * 2008-01-02 2009-07-02 Dade Behring Inc. Methods for detection of cyclosporin a
WO2011087813A2 (en) * 2009-12-22 2011-07-21 University Of Washington Capillarity-based devices for performing chemical processes and associated systems and methods
US9678068B2 (en) * 2010-03-01 2017-06-13 Quanterix Corporation Ultra-sensitive detection of molecules using dual detection methods
US10088490B2 (en) * 2010-08-20 2018-10-02 Siemens Healthcare Diagnostics Inc. Assay for analytes using multiple receptors
CN102565381B (zh) * 2010-12-08 2014-06-18 中国科学院生态环境研究中心 导电微粒子介导电化学发光信号的免疫检测方法
CA2856382C (en) 2011-11-22 2020-07-14 Siemens Healthcare Diagnostics Inc. Devices containing dried reagents for reconstitution as calibration and/or quality control solutions, and methods of production and use thereof
EP3418743B1 (en) * 2013-03-15 2020-04-29 Siemens Healthcare Diagnostics Inc. Luminescent oxygen channeling immunoassays utilizing electrochemical discharge of singlet oxygen and methods of production and use thereof
KR101653701B1 (ko) 2013-03-15 2016-09-02 지멘스 헬쓰케어 다이아그노스틱스 인크. 미세유체 분배 장치
WO2014152322A1 (en) 2013-03-15 2014-09-25 Siemens Healthcare Diagnostics Inc. Heterogeneous luminescent oxygen channeling immunoassays
US20160025736A1 (en) 2013-03-15 2016-01-28 Siemens Healthcare Diagnostics Inc. Heterogeneous luminescent oxygen channeling immunoassays and methods of production and use thereof
JP6693872B2 (ja) * 2013-07-25 2020-05-13 シトムクス セラピューティクス,インコーポレイティド 多重特異性抗体、多重特異性活性化可能抗体、及びそれらの使用方法
US20160320415A1 (en) * 2013-12-16 2016-11-03 Xen Biofluidx, Inc. Fast reconstituting reagent pellets

Also Published As

Publication number Publication date
EP3123151A1 (en) 2017-02-01
US20210231647A1 (en) 2021-07-29
EP3123151A4 (en) 2017-03-22
EP3123151B1 (en) 2018-11-28
CA2942281A1 (en) 2015-10-01
US12366571B2 (en) 2025-07-22
MX2016011809A (es) 2017-05-10
IL247630A0 (en) 2016-11-30
DK3483593T3 (da) 2021-07-19
EP3483593A1 (en) 2019-05-15
US20260104406A1 (en) 2026-04-16
CN106662532A (zh) 2017-05-10
AU2015236288A1 (en) 2016-09-15
WO2015148479A1 (en) 2015-10-01
ES2884930T3 (es) 2021-12-13
CA2942281C (en) 2023-03-14
DK3123151T3 (en) 2019-03-18
ES2713428T3 (es) 2019-05-21
CN106662532B (zh) 2019-12-13
JP2017508971A (ja) 2017-03-30
EP3483593B1 (en) 2021-04-28
US20170176419A1 (en) 2017-06-22
JP6596440B2 (ja) 2019-10-23

Similar Documents

Publication Publication Date Title
MX2016011809A (es) Inmunoensayo de canalización de oxígeno luminiscente utilizando tres anticuerpos y metodos de produccion y uso de los mismos.
CY1124993T1 (el) Ετεροδιμερικα αντισωματα που δεσμευουν cd3 και cd20
AR120262A2 (es) Anticuerpos madurados por afinidad y humanizados para fcrh5 y métodos para su uso
MX2017001597A (es) Anticuerpos anti-pd-l1.
MX2020000960A (es) Anticuerpos anti-tigit.
MX2021006237A (es) Anticuerpos anti-tigit, anticuerpos anti-pvrig y combinaciones de estos.
EA201792467A1 (ru) Гетеродимерные антитела, которые связывают cd3 и опухолевые антигены
MX2018008369A (es) Anticuerpos de anti-miostatina pro/latente y metodo de uso de los mismos.
EA201891709A1 (ru) Антигенсвязывающие белки, связывающие pd-l1
PH12018500766A1 (en) Bispecific antibodies with tetravalency for a costimulatory tnf receptor
CL2018000479A1 (es) Linfoopeitina strimal tomica (tslp) - anticuerpos de union y metodos de uso de los anticuerpos
JO3798B1 (ar) الأجسام المضادة ملزمة على وجه التحديد pd-1 واستخداماتها
MX2017014139A (es) Anticuerpos anti-cd71, anticuerpos anti-cd71 activables, y metodos de uso de los mismos.
ECSP18000844A (es) Anticuerpos de unión a tau
MX380937B (es) Anticuerpos dobles especificos.
EA201691321A1 (ru) Антитела и способы их применения
AR119997A1 (es) Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecíficos anti-klk5 / klk7 y métodos de uso
UY37083A (es) Anticuerpos anti-ror1, anticuerpos biespecíficos ror1 x cd3 y métodos para su uso
BR112018071276A2 (pt) anticorpos anti-il-33, composições, métodos e usos dos mesmos
NZ631098A (en) Anti-hepcidin antibodies and uses thereof
CR20210225A (es) RECEPTORES DE ANTÍGENES QUIMÉRICOS BASADOS EN ANTICUERPOS DE DOMINIO SIMPLE Y MÉTODOS DE USO DE ESTOS (Divisional 2018-0153)
CR20220186A (es) ANTICUERPOS ANTI-TIGIT Y MÉTODOS DE USO (divisional 2018-0225)
ECSP18000887A (es) Anticuerpos de unión a tau
BR112015022260A2 (pt) anticorpo monoclonal, polinucleotídeo, composição farmacêutica, fragmento isolado de tau, uso de um anticorpo, método de triagem de um agente e ácido nucleico
EA201690617A1 (ru) Комбинирование anti-lag-3-антител и анти-pd-1-антител для лечения опухолей

Legal Events

Date Code Title Description
FG Grant or registration